1 / 23

Dermatology Aspects of Cutaneous T-cell Lymphoma

Dermatology Aspects of Cutaneous T-cell Lymphoma. Dr. Raed Alhusayen MD, FRCPC Division of Dermatology Sunnybrook Health Sciences Centre Cutaneous Lymphoma Patient Education Forum April 14, 2012. Objectives .

austine
Télécharger la présentation

Dermatology Aspects of Cutaneous T-cell Lymphoma

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Dermatology Aspects of Cutaneous T-cell Lymphoma Dr. Raed Alhusayen MD, FRCPC Division of Dermatology Sunnybrook Health Sciences Centre Cutaneous Lymphoma Patient Education Forum April 14, 2012

  2. Objectives • Brief description of cutaneous T-cell lymphoma (CTCL): focus on Mycosis Fungoides • The role of the dermatologist in CTCL • Treatment options for early stage disease

  3. CTCL Abnormal growth of T-lymphocytes (a type of blood cells) in the skin

  4. CTCL

  5. CTCL

  6. Skin lesions • patches of erythema and scaling • Slightly raised plaques (Majority of patients)

  7. Skin lesions • Tumors

  8. Skin lesions • Erythroderma

  9. Other skin presentations

  10. The role of the dermatologist • Making the diagnosis: • History and physical examination • Skin biopsy(ies) • Workup (staging): • Blood work • Radiological studies (if required):CXR, US, CT • Treatment

  11. Why does it take so long to diagnose MF? • On average it takes 3 years from the development of skin lesions • It is a rare disease • It mimics other common skin diseases • It could be asymptomatic limited disease • Even if suspected, the skin biopsies might not be diagnostic • Multiple biopsies over a period of time might be needed

  12. Staging of Mycosis Fungoides

  13. Staging of Mycosis Fungoides

  14. Treatment options “Rarely progresses, frequently relapses” • Active observation • Topical agents: • Topical steroids: symptomatic lesions • Imiquimod (Aldara): localized lesions • Topical Retinoids (Tazarotene): localized lesions • Intralesional steroids

  15. Aldara reaction

  16. Phototherapy • Performed at PERC • More than 500 CTCL patients (350 active) • NBUVB (3x/wk): very effective on patches and thin plaques, less toxicity • PUVA (2x/wk): thicker plaques, longer remission

  17. Systemic Isotretinoin • Vitamin A derivative • Especially helpful when combined with phototherapy • Very well tolerated at low doses • Does not suppress the immune system • TERATOGENIC • Need to monitor lipid profile and liver enzymes

  18. Steps to manage the itch • Bathing with lukewarm water followed by gently patting the skin dry • Using moisturizers on regularly • Topical steroids • Oral antihistamines: Benadryl, Atarax, Doxepin • Low dose oral prednisone

  19. St Johns Institute of Dermatology

  20. Cutaneous lymphoma team • Multidisciplinary Team: Dermatologist / Clinical Oncologist / Hematologist / NURSES • 50-60 patients (6-8 new) • Overall similar treatment approach (bexarotene notable exception) Interesting ideas: • Cutaneous lymphoma tumor board: reviewing all new cases and selected follow ups • Case manager: primary contact person for the patient • Low dose prednisone for symptom relief

  21. Resources • Cutaneous Lymphoma Foundation: http://www.clfoundation.org/

More Related